{
  "@context": {
    "bsc": "http://bioschemas.org/",
    "edam": "http://edamontology.org/",
    "rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
    "rdfs": "http://www.w3.org/2000/01/rdf-schema#",
    "sc": "http://schema.org/",
    "xsd": "http://www.w3.org/2001/XMLSchema#"
  },
  "@graph": [
    {
      "@id": "https://bio.tools/open_phacts_explorer",
      "@type": "sc:SoftwareApplication",
      "sc:additionalType": "Web application",
      "sc:applicationSubCategory": [
        {
          "@id": "edam:topic_2258"
        },
        {
          "@id": "edam:topic_0202"
        },
        {
          "@id": "edam:topic_3336"
        }
      ],
      "sc:author": "Ian Dunlop",
      "sc:citation": {
        "@id": "https://doi.org/10.1016/j.drudis.2012.05.016"
      },
      "sc:contributor": "Innovative Medicines Initiative (IMI)",
      "sc:description": "Interface to the Open PHACTS Discovery Platform and is built to answer the critical pharmacology questions defined by eight major pharmaceutical companies.",
      "sc:featureList": [
        {
          "@id": "edam:operation_2422"
        },
        {
          "@id": "edam:operation_0337"
        },
        {
          "@id": "edam:operation_2421"
        }
      ],
      "sc:funder": "Innovative Medicines Initiative (IMI)",
      "sc:license": "MIT",
      "sc:name": "Open PHACTS Explorer",
      "sc:provider": [
        "University of Manchester",
        "Open PHACTS Foundation",
        "cs.manchester.ac.uk"
      ],
      "sc:url": "http://www.openphacts.org/explorer",
      "sc:version": "1.5.0"
    },
    {
      "@id": "https://doi.org/10.1016/j.drudis.2012.05.016",
      "@type": "sc:CreativeWork"
    }
  ]
}